BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 13130139)

  • 1. Efficient and specific repair of sickle beta-globin RNA by trans-splicing ribozymes.
    Byun J; Lan N; Long M; Sullenger BA
    RNA; 2003 Oct; 9(10):1254-63. PubMed ID: 13130139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing RNA repair efficiency by combining trans-splicing ribozymes that recognize different accessible sites on a target RNA.
    Lan N; Rooney BL; Lee SW; Howrey RP; Smith CA; Sullenger BA
    Mol Ther; 2000 Sep; 2(3):245-55. PubMed ID: 10985955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribozyme-mediated repair of sickle beta-globin mRNAs in erythrocyte precursors.
    Lan N; Howrey RP; Lee SW; Smith CA; Sullenger BA
    Science; 1998 Jun; 280(5369):1593-6. PubMed ID: 9616120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA reprogramming of alpha-mannosidase mRNA sequences in vitro by myxomycete group IC1 and IE ribozymes.
    Fiskaa T; Lundblad EW; Henriksen JR; Johansen SD; Einvik C
    FEBS J; 2006 Jun; 273(12):2789-800. PubMed ID: 16817905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-splicing with the group I intron ribozyme from Azoarcus.
    Dolan GF; Müller UF
    RNA; 2014 Feb; 20(2):202-13. PubMed ID: 24344321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group I Intron-Based Therapeutics Through Trans-Splicing Reaction.
    Lee CH; Han SR; Lee SW
    Prog Mol Biol Transl Sci; 2018; 159():79-100. PubMed ID: 30340790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-ribozyme targeting of human alpha-globin gene expression.
    Shen TJ; Ikonomi P; Smith R; Noguchi CT; Ho C
    Blood Cells Mol Dis; 1999; 25(5-6):361-73. PubMed ID: 10660485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA Trans-Splicing Targeting Endogenous β-Globin Pre-Messenger RNA in Human Erythroid Cells.
    Uchida N; Washington KN; Mozer B; Platner C; Ballantine J; Skala LP; Raines L; Shvygin A; Hsieh MM; Mitchell LG; Tisdale JF
    Hum Gene Ther Methods; 2017 Apr; 28(2):91-99. PubMed ID: 28267358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells.
    Jones JT; Lee SW; Sullenger BA
    Nat Med; 1996 Jun; 2(6):643-8. PubMed ID: 8640554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA reprogramming and repair based on trans-splicing group I ribozymes.
    Fiskaa T; Birgisdottir AB
    N Biotechnol; 2010 Jul; 27(3):194-203. PubMed ID: 20219714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction of a trans-splicing ribozyme for restoring EGFP truncation mutation].
    Li B; Xiong YQ; Tu HB; Liu QC; Zou DT; Zhou WQ; Chen YY
    Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):748-53. PubMed ID: 16285516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Experimental Evolution of trans-Splicing Group I Intron Ribozymes.
    Müller UF
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28045452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans insertion-splicing: ribozyme-catalyzed insertion of targeted sequences into RNAs.
    Johnson AK; Sinha J; Testa SM
    Biochemistry; 2005 Aug; 44(31):10702-10. PubMed ID: 16060679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using 5'-PTMs to repair mutant beta-globin transcripts.
    Kierlin-Duncan MN; Sullenger BA
    RNA; 2007 Aug; 13(8):1317-27. PubMed ID: 17556711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia.
    Alami R; Gilman JG; Feng YQ; Marmorato A; Rochlin I; Suzuka SM; Fabry ME; Nagel RL; Bouhassira EE
    Blood Cells Mol Dis; 1999 Apr; 25(2):110-9. PubMed ID: 10389593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vivo selection method to optimize trans-splicing ribozymes.
    Olson KE; Müller UF
    RNA; 2012 Mar; 18(3):581-9. PubMed ID: 22274958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization and application of the group I ribozyme trans-splicing reaction.
    Einvik C; Fiskaa T; Lundblad EW; Johansen S
    Methods Mol Biol; 2004; 252():359-71. PubMed ID: 15017063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating group I intron catalytic efficiency in mammalian cells.
    Long MB; Sullenger BA
    Mol Cell Biol; 1999 Oct; 19(10):6479-87. PubMed ID: 10490588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the substrate specificity of a group I intron ribozyme.
    Zarrinkar PP; Sullenger BA
    Biochemistry; 1999 Mar; 38(11):3426-32. PubMed ID: 10079089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo comparison of hammerhead, hairpin, and hepatitis delta virus self-processing ribozyme cassettes.
    Chowrira BM; Pavco PA; McSwiggen JA
    J Biol Chem; 1994 Oct; 269(41):25856-64. PubMed ID: 7523395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.